申请人:UBE INDUSTRIES, LTD.
公开号:US20180186818A1
公开(公告)日:2018-07-05
The present invention provides a compound represented by the general formula (Ia) or a pharmacologically acceptable salt thereof. In the general formula (Ia), two R moieties each independently represent a C
1-3
alkyl group or the like; and R
1
, R
2
and R
3
each independently represent an optionally substituted linear or branched C
1-4
alkyl group.
本发明提供了一种由通用公式(Ia)表示的化合物或其药理可接受的盐。在通用公式(Ia)中,两个R基团各自独立地代表一个C1-3烷基团或类似物;而R1、R2和R3各自独立地代表一个可选地取代的线性或支链的C1-4烷基团。